‘State-of-Art’ WHO, ISO Certified leading pharmaceutical company manufacturing wide range of API products for global clients. Has state of art R&D setup for API development. They have a Biotech drug discovery R&D jointly developed with an Israeli partner for the development of Recombinant fusion proteins for the treatment and cure of asthma and Mastocytosis.Has several products for animal health. Company has several research tie-ups with leading institutions. Fully functional and profitable company.